MoonLake Immunotherapeutics (MLTX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
9. 55
-0.71
-6.9201%
$
910.13M Market Cap
- P/E Ratio
- Div Yield
1.38M Volume
-1.16 Eps
$ 10.26
Previous Close 
Want to track MLTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MoonLake Immunotherapeutics (MLTX) Statistics
Valuation metrics
Market Cap 910.13M
Enterprise value 533.76M
Trailing P/E (ttm) -2.81
Forward P/E -
PEG ratio 0.09
Price/Sales (ttm) -
Price/Book (mrq) 1.87
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.01M
Average volume (90 days) 1.11M
Price summary
52-Week low 8.8
52-Week high 23.29
Beta -
50-Day moving average 11.13
200-Day moving average 17.64
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.46%
Return on equity -0.83%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.27
Total debt (mrq) -
Total Debt/Equity (mrq) 0.24
Current ratio (mrq) 12.56%
Book value per share (mrq) 5.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
